Skip to content

Microdosing: all studies

Page 25 of 56: studies 241 to 250 of 555, newest first. Back to the microdosing overview

Research

Toward Predicting Acute Myeloid Leukemia Patient Response to 7 + 3 Induction Chemotherapy via Diagnostic Microdosing

Chemical Research in Toxicology August 28, 2018 Tiffany M. Scharadin, Michael Malfatti, Kurt W. Haack et al. 4 citations

Acute myeloid leukemia (AML) is a rare yet deadly cancer of the blood and bone marrow. Presently, induction chemotherapy with the DNA damaging drugs cytarabine (ARA-C) and idarubicin (IDA), known as 7 + 3, is the standard of care for most AML patients. However, 7 + 3 is a relatively ineffective therapy, particularly in older patients, and has serious therapy-related toxicities. Therefore, a...

Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats

Behavioural Pharmacology March 13, 2018 Rachel R. Horsley, Tomáš Páleníček, Jan Kolin et al. 52 citations

Short-term moderate doses of serotonergic and dissociative hallucinogens can be useful in the treatment of anxiety. Recently, a trend has developed for long-term intermittent 'microdosing' (usually one-tenth of a 'full' active dose), with reports of long-lasting relief from anxiety and related disorders; however, there is no scientific evidence for the efficacy of therapeutic microdosing nor to...

High-precision piezo-ejection ocular microdosing: Phase II study on local and systemic effects of topical phenylephrine

Therapeutic Delivery 2018

AIM: Conventional eyedropper-delivered volumes (25-50 µl) exceed the eye's usual tear-film volume (7 µl) and precorneal reservoir capacity, risking overflow and ocular/systemic complications. Piezoelectric high-precision microdosing may circumvent these limitations. Results & methodology: In this masked, nonrandomized, cross-over study, subjects (n = 12) underwent pupil dilation with topical...

Comparison of pharmacokinetics of newly discovered aromatase inhibitors by a cassette microdosing approach in healthy Japanese subjects.

Drug Metabolism and Pharmacokinetics December 2017 Hiroyuki Kusuhara, Tadayuki Takashima, Hisako Fujii et al.

The aim of the present study is to investigate the pharmacokinetics of our newly developed aromatase inhibitors (cetrozole and TMD-322) in healthy subjects by a cassette microdose strategy. A cocktail of cetrozole and TMD-322 was administered intravenously or orally (1.98 μg for each drug) to six healthy volunteers in a crossover fashion. Anastrozole (1.98 μg) was also included in the oral...

DOI: 10.1016/j.dmpk.2017.09.003 (opens in new tab) Full text (opens in new tab) Aromatase inhibitor Cassette dosing approach Lc–ms/ms Microdosing clinical trial +1

Human microdosing and mice xenograft data of AGM-130 applied to estimate efficacious doses in patients.

Cancer chemotherapy and pharmacology August 2017 Wan-Su Park, Gab-Jin Park, Seunghoon Han et al.

AGM-130 is a cyclin-dependent kinase inhibitor that exhibits dose-dependent efficacy in xenograft mouse models. During preclinical pharmacokinetic (PK) studies, mice and rats showed comparable PK parameters while dogs showed unusually high clearance (CL), which has made human PK prediction challenging. To address this discrepancy, we performed a human microdosing PK and developed a mouse PK/PD...

DOI: 10.1007/s00280-017-3373-y (opens in new tab) Full text (opens in new tab) Agm-130 Cancer Cyclin-dependent kinase Human microdose +1

Intra‐Target Microdosing – A Novel Drug Development Approach: Proof of Concept, Safety, and Feasibility Study in Humans

Clinical and Translational Science July 8, 2017 T. Burt, D. MacLeod, K. Lee et al.

Intra‐Target Microdosing (ITM) is a novel drug development approach aimed at increasing the efficiency of first‐in‐human (FIH) testing of new molecular entities (NMEs). ITM combines intra‐target drug delivery and “microdosing,” the subpharmacological systemic exposure. We hypothesized that when the target tissue is small (about 1/100th of total body mass), ITM can lead to target...

Microdosing technology of fertilizer for sorghum production at Shambat, Sudan

Cell Biology and Development June 16, 2017 Monirah Babiker Mohamed Arbab, Yassin Mohmad Ibrahim Dagash

Arbab MBM, Dagash YMI. 2017. Microdosing technology of fertilizer for sorghum production at Shambat, Sudan. Cell Biol Dev 1: 18-22. The study was conducted at the experimental farm of Sudan University of Science and Technology, College of Agricultural Studies; Khartoum North-Shambat, to investigate the agronomic response and efficiency of fertilizer microdosing in Sorghum. An experiment with...

The Use of Microdosing in the Development of Small Organic and Protein Therapeutics

Journal of Nuclear Medicine May 25, 2017 Mats Bergström 31 citations

Microdosing as a regulatory concept was introduced to facilitate exploratory studies in humans. The concept involves the use of very low doses of a radionuclide-labeled compound for imaging studies or for assessing plasma pharmacokinetics using equipment that has a highly sensitive readout. The supporting principle is that use of these low doses for a limited time in well-controlled, small...

DOI: 10.2967/jnumed.116.188037 (opens in new tab) Pharmacology Drug development Pharmacokinetics Small molecule

A Diagnostic Microdosing Approach to Investigate Platinum Sensitivity in Non-Small Cell Lung Cancer

International Journal of Cancer May 15, 2017 Si-si Wang, Maike Zimmermann, Hong-Yong Zhang et al.

The platinum‐based drugs cisplatin, carboplatin and oxaliplatin are often used for chemotherapy, but drug resistance is common. The prediction of resistance to these drugs via genomics is a challenging problem since hundreds of genes are involved. A possible alternative is to use mass spectrometry to determine the propensity for cells to form drug‐DNA adducts—the pharmacodynamic drug‐target...